The Ortho Vision Max from Ortho Clinical Diagnostics, Raritan, NJ, has received FDA premarket notification (510(k)) clearance, and is now commercially available in the United States in addition to Europe and Japan.

Clearance of the fully automated blood analyzer for high-volume transfusion medicine laboratories follows the 2015 release of the Ortho Vision analyzer, an instrument designed for small- to mid-sized transfusion labs. Together the analyzers form the Ortho Vision platform, delivering a uniquely integrated instrument suite that is part of a larger portfolio of products and services. Matching the needs of any facility, the Ortho Vision platform aims to improve workflow and standardize systems and processes, helping blood banking labs keep pace with growing pressure to increase productivity while remaining operationally efficient.


Robert Yates, Ortho-Clinical Diagnostics.

“Labs are continuously pushed to accomplish more with fewer resources—including staff— and Ortho can now ease those pressures in labs of every size and makeup,” says Robert Yates, chief operating officer at Ortho Clinical Diagnostics. “Whether they perform 15 tests per day or 150, the Ortho Vision platform helps labs better manage their contribution to the overall critical-care path.”

Ortho Vision Max was developed for labs conducting more than 50 types and screens per day, and it also supports such complex immunohematology testing as serial dilutions for titration studies, reflex tests, and selected cell antibody identification. Taking advantage of the system’s flexibility and responsiveness, transfusion medicine departments may process routine samples and stat orders as they are received, rather than waiting for a complete batch before running the instrument.

Heidi Casaletto, Ortho Clinical Diagnostics.

Heidi Casaletto, Ortho Clinical Diagnostics.

“Transfusion medicine departments are now focused not only on testing, but on connecting their work to patient outcomes,” says Heidi Casaletto, head of transfusion medicine at Ortho Clinical Diagnostics. “A comprehensive portfolio of products operating on a single platform means engaging with one user interface, ordering one set of consumables, one set of processes and procedures, and streamlining training for everyone in the department. It also means more rapid delivery of actionable results that would increase the efficiency of patient diagnosis and a recommended treatment plan.”

For more information, visit Ortho Clinical Diagnostics.